![](/img/cover-not-exists.png)
O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
Blumenschein, G., Ludwig, C., Thomas, G., Tan, E., Fanucchi, M., Santoro, A., Crawford, J., Breton, J., O'Brien, M., Khuri, F.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80215-6
Date:
July, 2005
File:
PDF, 130 KB
english, 2005